-+ 0.00%
-+ 0.00%
-+ 0.00%

Akari Therapeutics Files Patent Application for New ADC Candidate AKTX-102 Targeting CEACAM5 in Solid Tumors

Reuters·01/26/2026 13:45:14

Please log in to view news